Clinical Studies on PTSD and Substance Use Disorder Comorbidity

This dataset compiles information on studies designed to treat co-occurring Post-Traumatic Stress Disorder (PTSD) and Substance Use Disorder (SUD). It is authored by the United States Department of Veterans Affairs and was last updated in February 2026. The specific number of rows, columns, and data fields is not provided in the input.

Use Cases

• Analyze treatment outcomes for patients with both PTSD and SUD based on study design features.
• Identify common intervention types and their reported efficacy for the comorbid conditions.
• Examine demographic or clinical variables across studies to understand participant characteristics.

Strengths

• Data originates from the United States Department of Veterans Affairs, an authoritative source on veteran and mental health topics.
• Focuses on a specific and serious clinical comorbidity, with a 44.6% lifetime co-occurrence rate cited in the description.
• Includes studies designed to improve both PTSD and SUD conditions, as per the description.

Limitations

• The dataset's size, structure, and specific variables (rows, columns, sample data) are unknown, limiting immediate analytical utility.
• The description suggests the data is a compilation of study information, which may lack raw patient-level clinical trial data.
• Potential geographic or population bias, as the source is the U.S. Department of Veterans Affairs, which may focus on veteran populations.

Provenance

Source

United States Department of Veterans Affairs, via ICPSR Harvested Dataverse.

Collection Method

Compilation of information from studies developed and tested for co-occurring PTSD and SUD.

Freshness

Last updated on 2026-02-23.